IOVANCE BIOTHERAPEUTICS, INC.

IOVA · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $1.5B · 975 employees
392
SEC Filings
$4.34
Close 2026-08-05
975
Employees

Business Summary

Iovance Biotherapeutics is a commercial-stage biopharmaceutical company specializing in tumor infiltrating lymphocyte (TIL) cell therapies for solid tumor cancers. Its two commercial products are Amtagvi (lifileucel), the first FDA-approved one-time individualized T cell therapy for previously treated advanced melanoma, and Proleukin (aldesleukin), an IL-2 product used in the Amtagvi treatment regimen. The company conducts centralized, scalable manufacturing and has ongoing registrational trials in frontline melanoma and non-small cell lung cancer.

Latest Stock Quote

IOVA 2026-08-05 $4.34 O:$4.45 H:$4.55 L:$4.29 Vol:15.6M VWAP:$4.4144
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-13

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310001104659-26-018899EDGAR118K words
2025-02-272024-12-310001558370-25-001834EDGAR—
2024-02-282023-12-310001558370-24-002036EDGAR—
2023-02-282022-12-310001558370-23-002419EDGAR—
2022-02-242021-12-310001558370-22-001976EDGAR—
2021-02-252020-12-310001558370-21-001858EDGAR—
2020-02-252019-12-310001104659-20-024830EDGAR—
2019-02-282018-12-310001144204-19-010702EDGAR—
2018-03-122017-12-310001144204-18-014151EDGAR—
2017-03-092016-12-310001144204-17-013535EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-062026-06-300001104659-26-091716EDGAR—
2025-11-062025-09-300001104659-25-107470EDGAR87K words
2025-08-072025-06-300001558370-25-010807EDGAR—
2025-05-082025-03-310001558370-25-007009EDGAR—
2024-11-072024-09-300001558370-24-014905EDGAR—
2024-08-082024-06-300001558370-24-011641EDGAR—
2024-05-092024-03-310001558370-24-007646EDGAR—
2023-11-072023-09-300001558370-23-018029EDGAR—
2023-08-082023-06-300001558370-23-013988EDGAR—
2023-05-102023-03-310001558370-23-009134EDGAR—
2022-11-032022-09-300001558370-22-016295EDGAR—
2022-08-042022-06-300001558370-22-012263EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-060001104659-26-091619EDGAR—
2026-08-060001104659-26-092145EDGAR—
2026-03-200001104659-26-032774EDGAR1K words
2026-02-240001104659-26-018837EDGAR—
2026-01-090001104659-26-002323EDGAR—
2025-11-060001104659-25-107426EDGAR—
2025-08-290001104659-25-085650EDGAR—
2025-08-220001104659-25-081953EDGAR—
2025-08-190001104659-25-080304EDGAR—
2025-08-070001104659-25-075175EDGAR—

392 total filings indexed. 360 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

advanced-melanoma non-small-cell-lung-cancer-(nsclc) undifferentiated-pleomorphic-sarcoma-(ups) dedifferentiated-liposarcoma-(ddlps) solid-tumor-oncology til-(tumor-infiltrating-lymphocyte)-cell-therapy-manufacturing centralized-scalable-proprietary-manufacturing-process lymphodepletion-treatment-regimen

Company Identity

CIK0001425205
TickerIOVA
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.iovance.com
Listed2010-05-26

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 07f756855222089aacceef2c7906fde37cb08a8ac946302918695ce411031234
parent: b3657198defc40b2d453a2c3a7076bd4165391e930be815ea2e0ae251c5580a6
content hash: 0d7021d0ebe808dc2c33d50bbcafc3775795d45253fe436b77f01ceecb6fda5f
signed: 2026-08-11T19:04:31.017Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up IOVA using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on IOVA, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/IOVA (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.